Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Paul, FR

François Paul, Toulouse FR

Patent application numberDescriptionPublished
20110082070Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency - The invention relates to a medicament which comprises a peptide extract of avocado and which can also comprise a composition containing D-mannoheptulose and/or perseitol, such as a water-soluble extract of avocado sugars, and/or a peptide extract of lupine. The inventive medicament is intended for the treatment and/or prevention of illnesses that are linked to an alteration in innate and/or acquired immunity, through an increase in the production of anti-microbial peptides, preferably hBD-2, without inducing inflammatory reactions, irritations or intolerances.04-07-2011

Patent applications by François Paul, Toulouse FR

François Paul, Montgauch FR

Patent application numberDescriptionPublished
20100035816MEDICAMENT COMPRISING A PEPTIDE EXTRACT OF AVOCADO, WHICH IS INTENDED FOR THE TREATMENT AND PREVENTION OF ILLNESSES THAT ARE LINKED TO AN IMMUNE SYSTEM DEFICIENCY OR OXIDATIVE STRESS OR SKIN AGEING OR DRY SKIN - The invention relates to a medicament which comprises a peptide extract of avocado and which can also comprise a composition containing D-mannoheptulose an/or perseitol, such as a water-soluble extract of avocado sugars, and/or a peptide extract of lupine. The inventive medicament is intended for the treatment and/or prevention of illnesses that are linked to an alteration in innate and/or acquired immunity, through an increase in the production of anti-microbial peptides, preferably hBD-2, without inducing inflammatory reactions, irritations or intolerances.02-11-2010

François Paul, Toulouse FR

Patent application numberDescriptionPublished
20110082070Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency - The invention relates to a medicament which comprises a peptide extract of avocado and which can also comprise a composition containing D-mannoheptulose and/or perseitol, such as a water-soluble extract of avocado sugars, and/or a peptide extract of lupine. The inventive medicament is intended for the treatment and/or prevention of illnesses that are linked to an alteration in innate and/or acquired immunity, through an increase in the production of anti-microbial peptides, preferably hBD-2, without inducing inflammatory reactions, irritations or intolerances.04-07-2011

François Paul, Montgauch FR

Patent application numberDescriptionPublished
20100035816MEDICAMENT COMPRISING A PEPTIDE EXTRACT OF AVOCADO, WHICH IS INTENDED FOR THE TREATMENT AND PREVENTION OF ILLNESSES THAT ARE LINKED TO AN IMMUNE SYSTEM DEFICIENCY OR OXIDATIVE STRESS OR SKIN AGEING OR DRY SKIN - The invention relates to a medicament which comprises a peptide extract of avocado and which can also comprise a composition containing D-mannoheptulose an/or perseitol, such as a water-soluble extract of avocado sugars, and/or a peptide extract of lupine. The inventive medicament is intended for the treatment and/or prevention of illnesses that are linked to an alteration in innate and/or acquired immunity, through an increase in the production of anti-microbial peptides, preferably hBD-2, without inducing inflammatory reactions, irritations or intolerances.02-11-2010

Gael Paul, Aix-En-Provence FR

Patent application numberDescriptionPublished
20090201044 LOGIC PERFORMANCE IN CYCLIC STRUCTURES - Apparatus, systems, and methods may operate to identify state holding elements and functional logic elements in an original cyclic structure, and to insert additional state holding elements or initial tokens in series with the identified functional logic elements to create a modified cyclic structure, wherein the additional state holding elements or initial tokens have substantially identical functionality to the original state holding elements. Other activities may include coupling additional functional logic elements to output nodes of the modified cyclic structure, wherein the additional functional logic elements have substantially identical functionality to the original functional logic elements. Additional apparatus, systems, and methods are disclosed.08-13-2009
20100199234METHODS AND APPARATUSES FOR CIRCUIT DESIGN AND OPTIMIZATION - In one aspect of an embodiment, a method implemented on a data processing system for circuit design, includes: identifying one or more first portions (e.g., islands) of a design of a circuit, where each of the one or more first portions contains a set of elements interconnected via timing critical nets; and reporting inter-dependency between portions of the circuit in view of the one or more first portions. In one aspect of an embodiment, a method implemented on a data processing system for circuit design, includes: identifying a first portion (e.g., island) of a design of a circuit, the first portion containing a set of elements interconnected via timing critical nets; and performing a synthesis transformation of the first portion to isolate timing dependency of the first portion on a non-critical net connected to an element of the first portion.08-05-2010
20110016439RESET MECHANISM CONVERSION - Methods, circuits, and systems for converting reset mechanisms in a synchronous circuit design into a corresponding asynchronous representation are described. These may operate to convert synchronous state holding blocks that include reset signals to corresponding asynchronous dataflow logic blocks. A replicated reset token at a fraction of the operational frequency of the reset signal may be distributed to the locations of the asynchronous dataflow logic blocks. Additional methods, circuits, and systems are disclosed.01-20-2011
20110062991ASYNCHRONOUS CIRCUIT REPRESENTATION OF SYNCHRONOUS CIRCUIT WITH ASYNCHRONOUS INPUTS - A synchronous circuit design is converted to an asynchronous circuit by converting synchronous circuit logic to an asynchronous circuit logic, and converting one or more asynchronous inputs at a circuit boundary to an asynchronous input to the converted asynchronous circuit logic, such that the converted asynchronous input is operable to generate a token upon observing a change in state on the asynchronous input. One or more asynchronous outputs at a circuit boundary is converted to an asynchronous output from the converted asynchronous circuit logic, such that the converted asynchronous output is operable to output updated data as soon as changed data is received from the converted asynchronous circuit logic in the asynchronous output.03-17-2011
20110066873MULTI-CLOCK ASYNCHRONOUS LOGIC CIRCUITS - Methods, systems, and circuits for implementing multi-clock designs in asynchronous logic circuits are described. A method may include associating one or more data tokens with a clock domain of a multi-clock domain netlist. A durational relationship between a clock period associated with the clock domain and one or more other clock domains of the multi-clock domain netlist may be determined. Data tokens used in other clock domains may be transformed based on the determined relationship.03-17-2011
20110066986TOKEN ENHANCED ASYNCHRONOUS CONVERSION OF SYNCHONOUS CIRCUITS - A synchronous circuit design is converted to an asynchronous circuit by converting synchronous circuit logic to an asynchronous circuit logic, and one or more additional tokens into the converted asynchronous circuit. The circuit is initialized with a desired additional number of tokens placed in the asynchronous circuit, or a desired number of tokens are inserted at an input before taking tokens from an output.03-17-2011
20110078644ASYCHRONOUS SYSTEM ANALYSIS - Methods, systems, and circuits that implement timing analyses of an asynchronous system are described. A method may include converting a synchronous circuit design into an asynchronous representation, wherein a critical path may be identified. The critical path may be converted to a corresponding path in the synchronous circuit design. Additional methods, systems, and circuits are disclosed.03-31-2011

Patent applications by Gael Paul, Aix-En-Provence FR

Jean-Michel Paul, Metz FR

Patent application numberDescriptionPublished
20090203938USE OF PHOSPHORIC ESTERS AS DEPOSIT CONTROL AGENTS DURING THE SYNTHESIS, PURIFICATION OR REGENERATION OF (METH)ACRYLIC MONOMERS - The compounds of formula (I) are provided as deposition inhibitors which prevent the deposition of compounds of polymeric nature or resulting from addition reactions to (meth)acrylic double bonds during operations for the synthesis or purification or regeneration of (meth)acrylic monomers.08-13-2009
20090234161 METHOD FOR THE PRODUCTION OF (METH)ACRYLIC ANHYDRIDE - The present invention relates to an improved method for manufacturing (meth)acrylic anhydride by transanhydrization between (meth)acrylic acid and acetic anhydride, in the presence of air and in the presence of at least one polymerization inhibitor, characterized in that the polymerization inhibitor is chosen from the group formed from (a) metal salts of thiocarbamic or dithiocarbamic acid and their mixtures with a phenolic derivative or phenothiazine and its derivatives, and (b) N-oxyl compounds as a mixture with 2,6-di-tert-butyl-4-methylphenol taken alone or in the presence of 2,4-dimethyl-6-tert-butylphenol.09-17-2009
20100145092METHOD FOR THE SYNTHESIS OF (METH)ACRYLIC ESTERS CATALYSED BY A POLYOL TITANATE - The subject of the invention is a method for the synthesis of (meth)acrylic esters by transesterification in the presence of a catalyst corresponding to the formula [(R′O)06-10-2010
20100219371COMPOSITIONS BASED ON ALKYLIMIDAZOLIDONE (METH)ACRYLATES - The invention relates to special (meth)acrylic monomers, more particularly to solutions of alkylimidazolidone (meth)acrylates in heavy (meth)acrylic esters, and also to preparation thereof from solutions of alkylimidazolidone (meth)acrylates in water or in light (meth)acrylic esters. The solutions of the invention are particularly advantageous in UV-radiation-polymerizing or electron-beam-polymerizing paint or varnish applications09-02-2010
20100317892 METHOD FOR PREPARING (METH)ACRYLIC ANHYDRIDE - The present invention relates to an improved method for preparing (meth)acrylic anhydride (A(M)A12-16-2010
20110049423PREPARATION OF ALKYLIMIDAZOLIDONE (METH)ACRYLATES IN WATER - The invention relates to special (methyl)acrylaic monomers and concerns more particularly an enhanced process for preparing solutions of alkylimiozolidone (meth)acrylates in water solutions of alkylimidazolidone (meth)acrylates in a light (meth)acrylate.03-03-2011

Patent applications by Jean-Michel Paul, Metz FR

Laurence Paul, Saint Leu La Foret FR

Patent application numberDescriptionPublished
20080260666Cosmetic compositions comprising at least one non-ionic surfactant and at least one vinylamide/vinylamine copolymer and methods of use thereof - Disclosed herein are cosmetic compositions comprising: 10-23-2008
20080267897Cosmetic compositions comprising at least one carboxylic anionic surfactant and at least one vinylamide/vinylamine copolymer, and processes of use thereof - Disclosed herein are cosmetic compositions comprising: 10-30-2008
20080286218Cosmetic Compositions Containing at Least One Conditioning Agent and at Least One Ethylene Polymer with Polyethylene Glycol Grafts - The invention concerns cosmetic compositions comprising: A) at least one conditioning agent selected among synthetic oils, mineral oils, vegetable oils, fluorinated and perfluorinated oils, natural or synthetic waxes, silicones, cationic polymers whereof the cationic filler density is less than 5 meq/g, cationic proteins, cationic protein hydrolysates, ceramide type compounds, cationic surfactants, fatty amines, fatty acids and their derivatives, as well as mixtures of those various compounds, and B) at least one ethylene copolymer comprising, in weight percentage based on the total weight of the polymer: a) 10-60 wt. % of one or more monomers of formula (I) as defined below; b) 40-90 wt. % of a substantially cationic monomer selected among (i) one or more cationic monomers of formula (IIa); (ii) one or more amphoteric monomers of formulae (IIc) and (IId); and (iii) a mixture of one or more cationic monomers of formula (IIa) with one or more anionic monomers selected among maleic anhydride and/or those of formula (IIb); and/or with one or more amphoteric monomers selected among those of formulae (IIc) and (IId), c) an optionally 0-50 wt. % of nonionic hydrophilic monomers, excluding methyl acrylate, methyl methacrylate and isopropyl acrylate when they are present in an amount not less than 10 wt. %. Hair treated with said compositions are more easily disentangled during rinsing, and exhibits softness after drying. The inventive compositions also allow particularly interesting hair brushing after drying.11-20-2008
20080311066Cosmetics Compositions Comprising at Least One Surfactant and at Least One Novel Ethylene Copolymer with Polyethylene Glycol Grafts - The invention relates to cosmetic compositions comprising: 12-18-2008
20090048132Detergent cosmetic compositions comprising four surfactants, a cationic polymer, and a beneficial agent and uses thereof - The disclosure relates to novel detergent and conditioning compositions comprising, in a cosmetically acceptable aqueous medium, (A) at least one anionic surfactant comprising at least one group chosen from sulfate, sulfonate and phosphate, (B) at least one carboxylic anionic surfactant other than the at least one anionic surfactant of (A), (C) at least one amphoteric or zwitterionic surfactant, (D) at least one alkylpolyglycoside nonionic surfactant, (E) at least one cationic polymer with a cationic charge density of greater than or equal to 4 meq./g, and (F) at least one beneficial agent other than the at least one cationic polymer of (E), wherein the sulfate, sulfonate or phosphate anionic surfactant/amphoteric surfactant weight ratio is in a range from 0.1 to 2. Also disclosed are uses of said composition for cleansing and caring for the hair or the skin.02-19-2009
20100258141METHOD FOR TREATING KERATINOUS FIBERS USING STEAM - Provided is a method for treating keratinous fibers comprising: applying steam to the keratinous fibers at a rate of less than 5 g/min; and shaping the keratinous fibers at a temperature of greater than 50° C., wherein the application of the steam and the shaping of the keratinous fibers do not occur simultaneously. The method disclosed herein may make it possible for example to obtain rapid shaping of the keratinous fibers while improving their cosmetic properties and the comfort of the user.10-14-2010

Patent applications by Laurence Paul, Saint Leu La Foret FR

Pascale Paul, Marseille FR

Patent application numberDescriptionPublished
20100112605Biomarker for the Medicine and the Biology of the Reproduction - The present invention relates to a new biomarker for the medicine and the biology of reproduction, in particular for in vitro fertilization (IVF) outcome. It relates to methods for predicting IVF outcome and for selecting the subject for IVF.05-06-2010

Pierre-Mary Paul, Draveil FR

Patent application numberDescriptionPublished
20090279167Device for amplifying high-energy ultrashort light pulses - A device for amplifying high-energy ultrashort light pulses, includes a generator (11-12-2009
20100316085HIGH POWER SOLID-STATE OPTICAL AMPLIFICATION PROCESS AND SYSTEM - A high power solid-state non-regenerative optical amplification system (12-16-2010

Stephane Paul, Strasbourg FR

Patent application numberDescriptionPublished
20090317422USE OF PPD FOR THE ADJUVANTATION OF A NUCLEIC ACID VACCINE - The present invention provides a novel adjuvant for nucleic acid vaccines, and in particular the present invention provides nucleic acid vaccines that comprise, or are administered in association with PPD. The present invention also provides methods to improve the therapeutic efficacy of nucleic acid vaccines.12-24-2009
20100074869Multifunctional Cytokines - The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.03-25-2010
20100129403RECOMBINANT VIRAL VACCINE - The present invention concerns new recombinant viral vaccines. In particular the present invention provides combination products that comprise recombinant viral vectors and specific compounds able to improve the immune response raised in vivo by said recombinant viral vectors.05-27-2010

Patent applications by Stephane Paul, Strasbourg FR

Stéphane Paul, Strasbourg Cedex FR

Patent application numberDescriptionPublished
20100196324MULTIFUNCTIONAL CYTOKINES - The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.08-05-2010

Stéphane Paul, Strasbourg FR

Patent application numberDescriptionPublished
20090317422USE OF PPD FOR THE ADJUVANTATION OF A NUCLEIC ACID VACCINE - The present invention provides a novel adjuvant for nucleic acid vaccines, and in particular the present invention provides nucleic acid vaccines that comprise, or are administered in association with PPD. The present invention also provides methods to improve the therapeutic efficacy of nucleic acid vaccines.12-24-2009

Stéphane Paul, Strasbourg Cedex FR

Patent application numberDescriptionPublished
20100196324MULTIFUNCTIONAL CYTOKINES - The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.08-05-2010

Stéphane Paul, Saint Just Saint Rambert FR

Patent application numberDescriptionPublished
20100055069HPV-18-BASED PAPILLOMAVIRUS VACCINES - Compositions containing one or more early polypeptide(s) of human papillomavirus (HPV)-18 or a nucleic acid encoding one or more early polypeptide(s) of HPV-18 are useful for preventing or treating an infection or a pathological condition caused by at least one papillomavirus other than HPV-18; the subject compositions are of very special interest in immunotherapy, in particular for preventing or treating HPV persistent infections that might promote cervical intraepithelial neoplasia (CIN) and ultimately cervical cancer.03-04-2010
20100061957HPV-16-BASED PAPILLOMAVIRUS VACCINES - Compositions containing one or more early polypeptide(s) of human papillomavirus (HPV)-16 or a nucleic acid encoding one or more early polypeptide(s) of HPV-16 are useful for preventing or treating an infection or a pathological condition caused by at least one papillomavirus other than HPV-16; the subject compositions are of very special interest in immunotherapy, in particular for preventing or treating HPV persistent infections that might promote cervical intraepithelial neoplasia (CIN) and ultimately cervical cancer.03-11-2010

Stéphane Paul, Saint Just Saint Rambert FR

Patent application numberDescriptionPublished
20100055069HPV-18-BASED PAPILLOMAVIRUS VACCINES - Compositions containing one or more early polypeptide(s) of human papillomavirus (HPV)-18 or a nucleic acid encoding one or more early polypeptide(s) of HPV-18 are useful for preventing or treating an infection or a pathological condition caused by at least one papillomavirus other than HPV-18; the subject compositions are of very special interest in immunotherapy, in particular for preventing or treating HPV persistent infections that might promote cervical intraepithelial neoplasia (CIN) and ultimately cervical cancer.03-04-2010
20100061957HPV-16-BASED PAPILLOMAVIRUS VACCINES - Compositions containing one or more early polypeptide(s) of human papillomavirus (HPV)-16 or a nucleic acid encoding one or more early polypeptide(s) of HPV-16 are useful for preventing or treating an infection or a pathological condition caused by at least one papillomavirus other than HPV-16; the subject compositions are of very special interest in immunotherapy, in particular for preventing or treating HPV persistent infections that might promote cervical intraepithelial neoplasia (CIN) and ultimately cervical cancer.03-11-2010

Wyatt Paul, Pont Du Chateau FR

Patent application numberDescriptionPublished
20090042300METHOD FOR ENHANCING GENE EXPRESSION IN PLANTS - The invention relates to the field of gene expression in plants and describes methods and constructs using the first intron of a FAD2 gene in order to enhance gene expression.02-12-2009
20090293155METHOD FOR PERFORMING HOMOLOGOUS RECOMBINATION IN PLANTS - The invention relates to modified restriction enzymes capable of being used for promoting homologous recombination in organisms, in particular plants, making it possible to either target gene integration or excise unwanted DNA sequences in the genome of said organisms.11-26-2009

Wyatt Paul, Aubiere FR

Patent application numberDescriptionPublished
20080313778Emp4 Gene - The present invention relates to altering plant development and more particularly to altering the development of the plant endosperm. It concerns in particular nucleic acid molecules which alter the endosperm development.12-18-2008
20090307795ZMTCRR-1 PLANT SIGNAL TRANSDUCTION GENE AND PROMOTER - The present invention relates to the improvement of agronomic qualities of plants. It concerns in particular a nucleic acid molecule encoding a plant signal transduction protein that modulates agronomic qualities of plants.12-10-2009

Xavier Paul, Chamallers FR

Patent application numberDescriptionPublished
20090218459Device for Fixing a Module on the Inner Wall of a Tire - A device for fixing a module to the internal wall of a tire. The device includes a support secured to the tire, the support having at least two independent straps secured to the support and means for immobilizing the module, the straps being oriented radially.09-03-2009

Xavier Paul, Chamalieres FR

Patent application numberDescriptionPublished
20090159169Device for Fixing a Module on the Inner Wall of a Tire - A device for fixing a module to the internal wall of a tire. This device includes a support secured to the tire and of a flexible strip, the support including means for fixing said strip, the ends of the strip having at least two independent means for attaching the module, and the strip having means for immobilizing the module.06-25-2009